papaverine has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chorostowska-Wynimko, J; Kus, J; Skopińska-Rózewska, E | 1 |
1 other study(ies) available for papaverine and 1,3-dipropyl-8-cyclopentylxanthine
| Article | Year |
|---|---|
Theophylline inhibits free oxygen radicals production by human monocytes via phosphodiesterase inhibition.
Topics: Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Monocytes; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Reactive Oxygen Species; Receptor, Adenosine A1; Receptors, Adenosine A2; Theophylline; Xanthines | 2007 |